Fairfield, Bush & Co’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,000
| Closed | -$235K | – | 421 |
|
|
2023
Q2 | $235K | Hold |
5,000
| – | – | 0.06% | 139 |
|
|
2023
Q1 | $210K | Buy |
+5,000
| New | +$210K | 0.07% | 137 |
|
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$222K | – | 158 |
|
|
2021
Q3 | $222K | Buy |
+5,000
| New | +$222K | 0.07% | 152 |
|
|
2021
Q2 | – | Sell |
-5,000
| Closed | -$374K | – | 161 |
|
|
2021
Q1 | $374K | Hold |
5,000
| – | – | 0.11% | 129 |
|
|
2020
Q4 | $433K | Hold |
5,000
| – | – | 0.13% | 111 |
|
|
2020
Q3 | $306K | Hold |
5,000
| – | – | 0.1% | 118 |
|
|
2020
Q2 | $208K | Buy |
+5,000
| New | +$208K | 0.07% | 132 |
|